Pediatr Infect Vaccine.  2022 Apr;29(1):1-15. 10.14776/piv.2022.29.e1.

Therapeutics in the Treatment of COVID-19 for Children and Adolescents

Affiliations
  • 1Department of Pediatrics, Pusan National University Hospital, Busan, the Republic of Korea
  • 2Department of Pediatrics, Jeju National University School of Medicine, Jeju, the Republic of Korea
  • 3Department of Pediatrics, Seoul National University College of Medicine, Seoul, the Republic of Korea

Abstract

Coronavirus disease 2019 (COVID-19) presents as a mild-to-moderate respiratory illness in most children. However, a small proportion of children with COVID-19 develop severe or critical illnesses. Although pediatric clinical trials for the treatment of COVID-19 are sparse, some drugs are available for children and adolescents with severe COVID-19. This review summarizes clinical data focusing on antiviral agents and immunomodulators for use in treating COVID-19. In addition, current recommendations for therapeutics for children and adolescents with COVID-19 are discussed.

Keyword

COVID-19; Therapeutics; Child; Adolescent
Full Text Links
  • PIV
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr